Report Detail

Human oocyte cryopreservation (egg freezing) is a procedure to preserve a woman's eggs (oocytes).The eggs are extracted, frozen and stored. The intention of the procedure is that the woman may choose to have the eggs thawed, fertilized, and transferred to the uterus as embryos to facilitate a pregnancy in the future.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oocyte Cryopreservation market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Oocyte Cryopreservation industry.
Based on our recent survey, we have several different scenarios about the Oocyte Cryopreservation YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Oocyte Cryopreservation will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Oocyte Cryopreservation market: Drivers and Restraints
This section covers the various factors driving the global Oocyte Cryopreservation market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by value and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.
Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.
Global Oocyte Cryopreservation market: Segment Analysis
The global Oocyte Cryopreservation market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided revenue according to the consumption of the product.
Global Oocyte Cryopreservation market: Regional Analysis
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
Global Oocyte Cryopreservation market: Key Players
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
By the type, the market is primarily split into
Slow-cooling Method
Flash-freezing Process (Vitrification)
By the application, this report covers the following segments
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
Competitive Landscape:
The Oocyte Cryopreservation key manufacturers in this market include:
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
Extend Fertility
HRC Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Monash IVF
Pacific Fertility Center-Los Angeles (PFCLA)
PIVET
Prelude Fertility
Queensland Fertility Group (QFG)
Reproductive Biology Associates
San Diego Fertility Center (SDFC)
Shady Grove Fertility
Sims IVF
VivaNeo Deutschland
West Coast Fertility Centers


1 Market Overview of Oocyte Cryopreservation

  • 1.1 Oocyte Cryopreservation Market Overview
    • 1.1.1 Oocyte Cryopreservation Product Scope
    • 1.1.2 Market Status and Outlook
  • 1.2 Global Oocyte Cryopreservation Market Size Overview by Region 2015 VS 2020 VS 2026
  • 1.3 Global Oocyte Cryopreservation Market Size by Region (2015-2026)
  • 1.4 Global Oocyte Cryopreservation Historic Market Size by Region (2015-2020)
  • 1.5 Global Oocyte Cryopreservation Market Size Forecast by Region (2021-2026)
  • 1.6 Key Regions Oocyte Cryopreservation Market Size YoY Growth (2015-2026)
    • 1.6.1 North America Oocyte Cryopreservation Market Size YoY Growth (2015-2026)
    • 1.6.2 Europe Oocyte Cryopreservation Market Size YoY Growth (2015-2026)
    • 1.6.3 China Oocyte Cryopreservation Market Size YoY Growth (2015-2026)
    • 1.6.4 Rest of Asia Pacific Oocyte Cryopreservation Market Size YoY Growth (2015-2026)
    • 1.6.5 Latin America Oocyte Cryopreservation Market Size YoY Growth (2015-2026)
    • 1.6.6 Middle East & Africa Oocyte Cryopreservation Market Size YoY Growth (2015-2026)
  • 1.7 Coronavirus Disease 2019 (Covid-19): Oocyte Cryopreservation Industry Impact
    • 1.7.1 How the Covid-19 is Affecting the Oocyte Cryopreservation Industry
      • 1.7.1.1 Oocyte Cryopreservation Business Impact Assessment - Covid-19
      • 1.7.1.2 Supply Chain Challenges
      • 1.7.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.7.2 Market Trends and Oocyte Cryopreservation Potential Opportunities in the COVID-19 Landscape
    • 1.7.3 Measures / Proposal against Covid-19
      • 1.7.3.1 Government Measures to Combat Covid-19 Impact
      • 1.7.3.2 Proposal for Oocyte Cryopreservation Players to Combat Covid-19 Impact

    2 Oocyte Cryopreservation Market Overview by Type

    • 2.1 Global Oocyte Cryopreservation Market Size by Type: 2015 VS 2020 VS 2026
    • 2.2 Global Oocyte Cryopreservation Historic Market Size by Type (2015-2020)
    • 2.3 Global Oocyte Cryopreservation Forecasted Market Size by Type (2021-2026)
    • 2.4 Slow-cooling Method
    • 2.5 Flash-freezing Process (Vitrification)

    3 Oocyte Cryopreservation Market Overview by Type

    • 3.1 Global Oocyte Cryopreservation Market Size by Application: 2015 VS 2020 VS 2026
    • 3.2 Global Oocyte Cryopreservation Historic Market Size by Application (2015-2020)
    • 3.3 Global Oocyte Cryopreservation Forecasted Market Size by Application (2021-2026)
    • 3.4 25-30 Year Old Female
    • 3.5 30-35 Year Old Female
    • 3.6 35-40 Year Old Female
    • 3.7 Others

    4 Global Oocyte Cryopreservation Competition Analysis by Players

    • 4.1 Global Oocyte Cryopreservation Market Size (Million US$) by Players (2015-2020)
    • 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oocyte Cryopreservation as of 2019)
    • 4.3 Date of Key Manufacturers Enter into Oocyte Cryopreservation Market
    • 4.4 Global Top Players Oocyte Cryopreservation Headquarters and Area Served
    • 4.5 Key Players Oocyte Cryopreservation Product Solution and Service
    • 4.6 Competitive Status
      • 4.6.1 Oocyte Cryopreservation Market Concentration Rate
      • 4.6.2 Mergers & Acquisitions, Expansion Plans

    5 Company (Top Players) Profiles and Key Data

    • 5.1 Anova Fertility
      • 5.1.1 Anova Fertility Profile
      • 5.1.2 Anova Fertility Main Business and Company’s Total Revenue
      • 5.1.3 Anova Fertility Products, Services and Solutions
      • 5.1.4 Anova Fertility Revenue (US$ Million) (2015-2020)
      • 5.1.5 Anova Fertility Recent Developments
    • 5.2 CCRM IVF
      • 5.2.1 CCRM IVF Profile
      • 5.2.2 CCRM IVF Main Business and Company’s Total Revenue
      • 5.2.3 CCRM IVF Products, Services and Solutions
      • 5.2.4 CCRM IVF Revenue (US$ Million) (2015-2020)
      • 5.2.5 CCRM IVF Recent Developments
    • 5.3 Chill
      • 5.5.1 Chill Profile
      • 5.3.2 Chill Main Business and Company’s Total Revenue
      • 5.3.3 Chill Products, Services and Solutions
      • 5.3.4 Chill Revenue (US$ Million) (2015-2020)
      • 5.3.5 CREATE Fertility Recent Developments
    • 5.4 CREATE Fertility
      • 5.4.1 CREATE Fertility Profile
      • 5.4.2 CREATE Fertility Main Business and Company’s Total Revenue
      • 5.4.3 CREATE Fertility Products, Services and Solutions
      • 5.4.4 CREATE Fertility Revenue (US$ Million) (2015-2020)
      • 5.4.5 CREATE Fertility Recent Developments
    • 5.5 Extend Fertility
      • 5.5.1 Extend Fertility Profile
      • 5.5.2 Extend Fertility Main Business and Company’s Total Revenue
      • 5.5.3 Extend Fertility Products, Services and Solutions
      • 5.5.4 Extend Fertility Revenue (US$ Million) (2015-2020)
      • 5.5.5 Extend Fertility Recent Developments
    • 5.6 HRC Fertility
      • 5.6.1 HRC Fertility Profile
      • 5.6.2 HRC Fertility Main Business and Company’s Total Revenue
      • 5.6.3 HRC Fertility Products, Services and Solutions
      • 5.6.4 HRC Fertility Revenue (US$ Million) (2015-2020)
      • 5.6.5 HRC Fertility Recent Developments
    • 5.7 IVF Australia
      • 5.7.1 IVF Australia Profile
      • 5.7.2 IVF Australia Main Business and Company’s Total Revenue
      • 5.7.3 IVF Australia Products, Services and Solutions
      • 5.7.4 IVF Australia Revenue (US$ Million) (2015-2020)
      • 5.7.5 IVF Australia Recent Developments
    • 5.8 Kindbody
      • 5.8.1 Kindbody Profile
      • 5.8.2 Kindbody Main Business and Company’s Total Revenue
      • 5.8.3 Kindbody Products, Services and Solutions
      • 5.8.4 Kindbody Revenue (US$ Million) (2015-2020)
      • 5.8.5 Kindbody Recent Developments
    • 5.9 London Women’s Clinic
      • 5.9.1 London Women’s Clinic Profile
      • 5.9.2 London Women’s Clinic Main Business and Company’s Total Revenue
      • 5.9.3 London Women’s Clinic Products, Services and Solutions
      • 5.9.4 London Women’s Clinic Revenue (US$ Million) (2015-2020)
      • 5.9.5 London Women’s Clinic Recent Developments
    • 5.10 Manchester Fertility
      • 5.10.1 Manchester Fertility Profile
      • 5.10.2 Manchester Fertility Main Business and Company’s Total Revenue
      • 5.10.3 Manchester Fertility Products, Services and Solutions
      • 5.10.4 Manchester Fertility Revenue (US$ Million) (2015-2020)
      • 5.10.5 Manchester Fertility Recent Developments
    • 5.11 Mayo Clinic
      • 5.11.1 Mayo Clinic Profile
      • 5.11.2 Mayo Clinic Main Business and Company’s Total Revenue
      • 5.11.3 Mayo Clinic Products, Services and Solutions
      • 5.11.4 Mayo Clinic Revenue (US$ Million) (2015-2020)
      • 5.11.5 Mayo Clinic Recent Developments
    • 5.12 Melbourne IVF
      • 5.12.1 Melbourne IVF Profile
      • 5.12.2 Melbourne IVF Main Business and Company’s Total Revenue
      • 5.12.3 Melbourne IVF Products, Services and Solutions
      • 5.12.4 Melbourne IVF Revenue (US$ Million) (2015-2020)
      • 5.12.5 Melbourne IVF Recent Developments
    • 5.13 Monash IVF
      • 5.13.1 Monash IVF Profile
      • 5.13.2 Monash IVF Main Business and Company’s Total Revenue
      • 5.13.3 Monash IVF Products, Services and Solutions
      • 5.13.4 Monash IVF Revenue (US$ Million) (2015-2020)
      • 5.13.5 Monash IVF Recent Developments
    • 5.14 Pacific Fertility Center-Los Angeles (PFCLA)
      • 5.14.1 Pacific Fertility Center-Los Angeles (PFCLA) Profile
      • 5.14.2 Pacific Fertility Center-Los Angeles (PFCLA) Main Business and Company’s Total Revenue
      • 5.14.3 Pacific Fertility Center-Los Angeles (PFCLA) Products, Services and Solutions
      • 5.14.4 Pacific Fertility Center-Los Angeles (PFCLA) Revenue (US$ Million) (2015-2020)
      • 5.14.5 Pacific Fertility Center-Los Angeles (PFCLA) Recent Developments
    • 5.15 PIVET
      • 5.15.1 PIVET Profile
      • 5.15.2 PIVET Main Business and Company’s Total Revenue
      • 5.15.3 PIVET Products, Services and Solutions
      • 5.15.4 PIVET Revenue (US$ Million) (2015-2020)
      • 5.15.5 PIVET Recent Developments
    • 5.16 Prelude Fertility
      • 5.16.1 Prelude Fertility Profile
      • 5.16.2 Prelude Fertility Main Business and Company’s Total Revenue
      • 5.16.3 Prelude Fertility Products, Services and Solutions
      • 5.16.4 Prelude Fertility Revenue (US$ Million) (2015-2020)
      • 5.16.5 Prelude Fertility Recent Developments
    • 5.17 Queensland Fertility Group (QFG)
      • 5.17.1 Queensland Fertility Group (QFG) Profile
      • 5.17.2 Queensland Fertility Group (QFG) Main Business and Company’s Total Revenue
      • 5.17.3 Queensland Fertility Group (QFG) Products, Services and Solutions
      • 5.17.4 Queensland Fertility Group (QFG) Revenue (US$ Million) (2015-2020)
      • 5.17.5 Queensland Fertility Group (QFG) Recent Developments
    • 5.18 Reproductive Biology Associates
      • 5.18.1 Reproductive Biology Associates Profile
      • 5.18.2 Reproductive Biology Associates Main Business and Company’s Total Revenue
      • 5.18.3 Reproductive Biology Associates Products, Services and Solutions
      • 5.18.4 Reproductive Biology Associates Revenue (US$ Million) (2015-2020)
      • 5.18.5 Reproductive Biology Associates Recent Developments
    • 5.19 San Diego Fertility Center (SDFC)
      • 5.19.1 San Diego Fertility Center (SDFC) Profile
      • 5.19.2 San Diego Fertility Center (SDFC) Main Business and Company’s Total Revenue
      • 5.19.3 San Diego Fertility Center (SDFC) Products, Services and Solutions
      • 5.19.4 San Diego Fertility Center (SDFC) Revenue (US$ Million) (2015-2020)
      • 5.19.5 San Diego Fertility Center (SDFC) Recent Developments
    • 5.20 Shady Grove Fertility
      • 5.20.1 Shady Grove Fertility Profile
      • 5.20.2 Shady Grove Fertility Main Business and Company’s Total Revenue
      • 5.20.3 Shady Grove Fertility Products, Services and Solutions
      • 5.20.4 Shady Grove Fertility Revenue (US$ Million) (2015-2020)
      • 5.20.5 Shady Grove Fertility Recent Developments
    • 5.21 Sims IVF
      • 5.21.1 Sims IVF Profile
      • 5.21.2 Sims IVF Main Business and Company’s Total Revenue
      • 5.21.3 Sims IVF Products, Services and Solutions
      • 5.21.4 Sims IVF Revenue (US$ Million) (2015-2020)
      • 5.21.5 Sims IVF Recent Developments
    • 5.22 VivaNeo Deutschland
      • 5.22.1 VivaNeo Deutschland Profile
      • 5.22.2 VivaNeo Deutschland Main Business and Company’s Total Revenue
      • 5.22.3 VivaNeo Deutschland Products, Services and Solutions
      • 5.22.4 VivaNeo Deutschland Revenue (US$ Million) (2015-2020)
      • 5.22.5 VivaNeo Deutschland Recent Developments
    • 5.23 West Coast Fertility Centers
      • 5.23.1 West Coast Fertility Centers Profile
      • 5.23.2 West Coast Fertility Centers Main Business and Company’s Total Revenue
      • 5.23.3 West Coast Fertility Centers Products, Services and Solutions
      • 5.23.4 West Coast Fertility Centers Revenue (US$ Million) (2015-2020)
      • 5.23.5 West Coast Fertility Centers Recent Developments

    6 North America Oocyte Cryopreservation by Players and by Application

    • 6.1 North America Oocyte Cryopreservation Market Size and Market Share by Players (2015-2020)
    • 6.2 North America Oocyte Cryopreservation Market Size by Application (2015-2020)

    7 Europe Oocyte Cryopreservation by Players and by Application

    • 7.1 Europe Oocyte Cryopreservation Market Size and Market Share by Players (2015-2020)
    • 7.2 Europe Oocyte Cryopreservation Market Size by Application (2015-2020)

    8 China Oocyte Cryopreservation by Players and by Application

    • 8.1 China Oocyte Cryopreservation Market Size and Market Share by Players (2015-2020)
    • 8.2 China Oocyte Cryopreservation Market Size by Application (2015-2020)

    9 Rest of Asia Pacific Oocyte Cryopreservation by Players and by Application

    • 9.1 Rest of Asia Pacific Oocyte Cryopreservation Market Size and Market Share by Players (2015-2020)
    • 9.2 Rest of Asia Pacific Oocyte Cryopreservation Market Size by Application (2015-2020)

    10 Latin America Oocyte Cryopreservation by Players and by Application

    • 10.1 Latin America Oocyte Cryopreservation Market Size and Market Share by Players (2015-2020)
    • 10.2 Latin America Oocyte Cryopreservation Market Size by Application (2015-2020)

    11 Middle East & Africa Oocyte Cryopreservation by Players and by Application

    • 11.1 Middle East & Africa Oocyte Cryopreservation Market Size and Market Share by Players (2015-2020)
    • 11.2 Middle East & Africa Oocyte Cryopreservation Market Size by Application (2015-2020)

    12 Oocyte Cryopreservation Market Dynamics

    • 12.1 Industry Trends
    • 12.2 Market Drivers
    • 12.3 Market Challenges
    • 12.4 Porter’s Five Forces Analysis

    13 Research Finding /Conclusion

      14 Methodology and Data Source

      • 14.1 Methodology/Research Approach
        • 14.1.1 Research Programs/Design
        • 14.1.2 Market Size Estimation
        • 14.1.3 Market Breakdown and Data Triangulation
      • 14.2 Data Source
        • 14.2.1 Secondary Sources
        • 14.2.2 Primary Sources
      • 14.3 Disclaimer

    Summary:
    Get latest Market Research Reports on Oocyte Cryopreservation. Industry analysis & Market Report on Oocyte Cryopreservation is a syndicated market report, published as Global Oocyte Cryopreservation Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Oocyte Cryopreservation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,772.00
    5,544.00
    3,234.00
    6,468.00
    529,515.00
    1,059,030.00
    291,795.00
    583,590.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report